Results 181 to 190 of about 84,866 (261)

The new German evidence- and consensus-based schizophrenia guideline. [PDF]

World Psychiatry
Hasan A, Falkai P, Leucht S, Gaebel W.
europepmc   +1 more source

An Electronic Health Record “Nudge” to Reduce Antipsychotic Medication Prescribing for Primary Care Patients With Dementia: A Pragmatic RCT

Journal of the American Geriatrics Society, EarlyView.
ABSTRACT Background We hypothesized that an electronic health record (EHR) alert grounded in behavioral science could reduce new antipsychotic medication prescriptions for older adults with dementia. Methods We conducted a pragmatic clinical trial at a large academic health system, randomizing providers to receive the alert (intervention) or not ...
Catherine A. Sarkisian, Chad Wes Villaflores, Anne M. Walling, Sitaram S. Vangala, Eric M. Cheng, Suzanne Bliven Shu, Ajaya Pillai, Grace Y. Cheng, Noah Goldstein, John Mafi   +9 more
wiley   +1 more source

Development of a patient decision aid prototype on the decision to continue, reduce or discontinue antipsychotic medication following remission of first-episode psychosis. [PDF]

BJPsych Open
Béchard L, Corbeil O, Huot-Lavoie M, Roy O, Brodeur S, Bouchard E, Martel J, Pavey N, Achim AM, Menear M, Roy MA, Lauzier S, Demers MF.   +12 more
europepmc   +1 more source

Anticholinergic Medication Use in Veterans Affairs Long‐Term Care Residents: Clinical Patterns and Opportunities for Deprescribing

Journal of the American Geriatrics Society, EarlyView.
ABSTRACT Background Anticholinergic exposure is common in nursing homes; however, the true burden may be underestimated, particularly due to over‐the‐counter agents such as first‐generation antihistamines that are not consistently captured in prior claims‐based studies.
Cellas A. Hayes, Yongmei Li, Bocheng Jing, Laura A. Graham, Chintan Dave, Michelle C. Odden   +5 more
wiley   +1 more source

The safety and efficacy of semaglutide in people with schizophrenia spectrum disorders: systematic review and meta-analysis of randomised controlled trials. [PDF]

BJPsych Open
Trott M, Arnautovska U, Johnston D, Ritchie G, Siskind D.   +4 more
europepmc   +1 more source

Case Report: Early onset pulmonary embolism following antipsychotic polypharmacy in an acute psychiatric setting. [PDF]

Front Psychiatry
Fesenmeier S, Aigner M, Filipovits D, Höflich A.   +3 more
europepmc   +1 more source

Hospice Care in the Era of AI: Hospices' Views on Data‐Driven Tools to Support Live Discharge Decisions

Journal of the American Geriatrics Society, EarlyView.
ABSTRACT Background Live discharge occurs for 20% of hospice enrollees, resulting in loss of support and disruptive care transitions, with higher risk for patients with Alzheimer's disease and related dementias (ADRD). Little is understood about how data‐driven clinical decision support tools (e.g., predictive algorithms) might support decision making ...
Elizabeth A. Luth, Caitlin Brennan, Susan Hurley, Kira G. Sheldon, Yongkang Zhang   +4 more
wiley   +1 more source

LiquidGAN for Handwriting-Based Detection and Severity Classification of Extrapyramidal Symptoms. [PDF]

Sensors (Basel)
Liyanage EM, Lee CH, Chang WY, Lee AA, Liaw GH, Yang WC, Liu YH, Lan KC, Ling SH.   +8 more
europepmc   +1 more source

Effects of the WeCareAdvisor Web App on Behavioral Symptoms and Caregiver Outcomes: A Randomized Trial

Journal of the American Geriatrics Society, EarlyView.
ABSTRACT Background Nonpharmacological strategies are first‐line treatments for behavioral symptoms, the most distressful aspect of dementia care. Few caregivers have knowledge of or access to effective strategies. We tested the effects of WeCareAdvisor, a web app to help caregivers problem‐solve and identify nonpharmacological strategies to manage ...
Laura N. Gitlin, Leslie A. McClure, Melinda J. Webster, Constantine Lyketsos, Helen C. Kales   +4 more
wiley   +1 more source